TNF-α increases lipogenesis via JNK and PI3K/Akt pathways in SZ95 human sebocytes

Journal of Dermatological Science

Volumn 65, Issue 3, 2012, Pages 179-188

  Choi, Jeong June ^a   Park, Min Young ^a   Lee, Hwa Jin ^b   Yoon, Do young ^c   Lim, Yoongho ^c   Hyun, Jin Won ^d   Zouboulis, Christos C ^e   Jin, Mirim ^a  

^a Daejeon University   (South Korea)

^b Sookmyung Women's University   (South Korea)

^c Konkuk University   (South Korea)

^d Jeju National University   (South Korea)

^e DESSAU MEDICAL CENTER   (Germany)

Author keywords

Akt; JNK; Lipogenesis; Sebocyte; SZ95 human sebocytes; TNF

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; FAT DROPLET; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ACNE; ARTICLE; CELL LINE; CELL STRAIN SZ95; CELL TYPE; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPOGENESIS; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEBACEOUS CELL; SEBORRHEA; STAINING; THIN LAYER CHROMATOGRAPHY; UPREGULATION; WESTERN BLOTTING;

ANTIGENS, CD95; CELL LINE; HUMANS; LIPID METABOLISM; LIPOGENESIS; MAP KINASE SIGNALING SYSTEM; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SEBACEOUS GLANDS; SIGNAL TRANSDUCTION; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862830141     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2011.11.005     Document Type: Article

References (45)

1. Smith K.R., Thiboutot D.M. Thematic review series: skin lipids. Sebaceous gland lipids: friend or foe?. J Lipid Res 2008, 49:271-281.
2. Schneider M.R., Paus R. Sebocytes, multifaceted epithelial cells: lipid production and holocrine secretion. Int J Biochem Cell Biol 2010, 42:181-185.
3. Zouboulis C.C., Chen W.C., Thornton M.J., Qin K., Rosenfield R. Sexual hormones in human skin. Horm Metab Res 2007, 39:85-95.
4. Smith T.M., Cong Z., Gilliland K.L., Clawson G.A., Thiboutot D.M. Insulin-like growth factor-1 induces lipid production in human SEB-1 sebocytes via sterol response element-binding protein-1. J Invest Dermatol 2006, 126:1226-1232.
5. Makrantonaki E., Vogel K., Fimmel S., Oeff M., Seltmann H., Zouboulis C.C. Interplay of IGF-I and 17beta-estradiol at age-specific levels in human sebocytes and fibroblasts in vitro. Exp Gerontol 2008, 43:939-946.
6. Alestas T., Ganceviciene R., Fimmel S., Muller-Decker K., Zouboulis C.C. Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands. J Mol Med 2006, 84:75-87.
7. Zouboulis Ch C., Saborowski A., Boschnakow A. Zileuton, an oral 5-lipoxygenase inhibitor, directly reduces sebum production. Dermatology 2005, 210:36-38.
8. Chen W., Yang C.C., Sheu H.M., Seltmann H., Zouboulis C.C. Expression of peroxisome proliferator-activated receptor and CCAAT/enhancer binding protein transcription factors in cultured human sebocytes. J Invest Dermatol 2003, 121:441-447.
9. Harrison W.J., Bull J.J., Seltmann H., Zouboulis C.C., Philpott M.P. Expression of lipogenic factors galectin-12, resistin, SREBP-1, and SCD in human sebaceous glands and cultured sebocytes. J Invest Dermatol 2007, 127:1309-1317.
10. Cho M.C., Lee K., Paik S.G., Yoon D.Y. Peroxisome proliferators-activated receptor (PPAR) modulators and metabolic disorders. PPAR Res 2008, 679137.
11. Trivedi N.R., Cong Z., Nelson A.M., Albert A.J., Rosamilia L.L., Sivarajah S., et al. Peroxisome proliferator-activated receptors increase human sebum production. J Invest Dermatol 2006, 126:2002-2009.
12. Hong I., Lee M.H., Na T.Y., Zouboulis C.C., Lee M.O. LXRalpha enhances lipid synthesis in SZ95 sebocytes. J Invest Dermatol 2008, 128:1266-1272.
13. Nagy I., Pivarcsi A., Kis K., Koreck A., Bodai L., McDowell A., et al. Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect 2006, 8:2195-2205.
14. Kim J., Ochoa M.T., Krutzik S.R., Takeuchi O., Uematsu S., Legaspi A.J., et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 2002, 169:1535-1541.
15. Rossol S., Voth R., Brunner S., Muller W.E., Buttner M., Gallati H., et al. Corynebacterium parvum (Propionibacterium acnes): an inducer of tumor necrosis factor-alpha in human peripheral blood mononuclear cells and monocytes in vitro. Eur J Immunol 1990, 20:1761-1765.
16. Graham G.M., Farrar M.D., Cruse-Sawyer J.E., Holland K.T., Ingham E. Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL. Br J Dermatol 2004, 150:421-428.
17. Jeremy A.H., Holland D.B., Roberts S.G., Thomson K.F., Cunliffe W.J. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 2003, 121:20-27.
18. Zouboulis C.C., Seltmann H., Neitzel H., Orfanos C.E. Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95). J Invest Dermatol 1999, 113:1011-1020.
19. Smith T.M., Gilliland K., Clawson G.A., Thiboutot D. IGF-1 induces SREBP-1 expression and lipogenesis in SEB-1 sebocytes via activation of the phosphoinositide 3-kinase/Akt pathway. J Invest Dermatol 2008, 128:1286-1293.
20. Zouboulis C.C., Schagen S., Alestas T. The sebocyte culture: a model to study the pathophysiology of the sebaceous gland in sebostasis, seborrhoea and acne. Arch Dermatol Res 2008, 300:397-413.
21. Bennett M.K., Lopez J.M., Sanchez H.B., Osborne T.F. Sterol regulation of fatty acid synthase promoter. Coordinate feedback regulation of two major lipid pathways. J Biol Chem 1995, 270:25578-25583.
22. Rao K.M. MAP kinase activation in macrophages. J Leukoc Biol 2001, 69:3-10.
23. Kyriakis J.M. Activation of the AP-1 transcription factor by inflammatory cytokines of the TNF family. Gene Expr 1999, 7:217-231.
24. Chang Y., Wang J., Lu X., Thewke D.P., Mason R.J. KGF induces lipogenic genes through a PI3K and JNK/SREBP-1 pathway in H292 cells. J Lipid Res 2005, 46:2624-2635.
25. Kotzka J., Muller-Wieland D., Roth G., Kremer L., Munck M., Schurmann S., et al. Sterol regulatory element binding proteins (SREBP)-1a and SREBP-2 are linked to the MAP-kinase cascade. J Lipid Res 2000, 41:99-108.
26. Campione E., Mazzotta A.M., Bianchi L., Chimenti S. Severe acne successfully treated with etanercept. Acta Derm Venereol 2006, 86:256-257.
27. Kang S., Cho S., Chung J.H., Hammerberg C., Fisher G.J., Voorhees J.J. Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo. Am J Pathol 2005, 166:1691-1699.
28. Bialecka A., Mak M., Biedron R., Bobek M., Kasprowicz A., Marcinkiewicz J. Different pro-inflammatory and immunogenic potentials of Propionibacterium acnes and Staphylococcus epidermidis: implications for chronic inflammatory acne. Arch Immunol Ther Exp (Warsz) 2005, 53:79-85.
29. Vowels B.R., Yang S., Leyden J.J. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun 1995, 63:3158-3165.
30. Chiang C.T., Weng M.S., Lin-Shiau S.Y., Kuo K.L., Tsai Y.J., Lin J.K. Pu-erh tea supplementation suppresses fatty acid synthase expression in the rat liver through downregulating Akt and JNK signalings as demonstrated in human hepatoma HepG2 cells. Oncol Res 2005, 16:119-128.
31. Engelman J.A., Lisanti M.P., Scherer P.E. Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis. J Biol Chem 1998, 273:32111-32120.
32. Hao J., Liu S., Zhao S., Liu Q., Lv X., Chen H., et al. PI3K/Akt pathway mediates high glucose-induced lipogenesis and extracellular matrix accumulation in HKC cells through regulation of SREBP-1 and TGF-beta1. Histochem Cell Biol 2011, 135:173-181.
33. Moon J.S., Jin W.J., Kwak J.H., Kim H.J., Yun M.J., Kim J.W., et al. Androgen stimulates glycolysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 in prostate cancer cells. Biochem J 2010, 433:225-233.
34. Kohn A.D., Summers S.A., Birnbaum M.J., Roth R.A. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 1996, 271:31372-31378.
35. Porstmann T., Griffiths B., Chung Y.L., Delpuech O., Griffiths J.R., Downward J., et al. PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene 2005, 24:6465-6481.
36. Du X., Kristiana I., Wong J., Brown A.J. Involvement of Akt in ER-to-Golgi transport of SCAP/SREBP: a link between a key cell proliferative pathway and membrane synthesis. Mol Biol Cell 2006, 17:2735-2745.
37. Downie M.M., Sanders D.A., Kealey T. Modelling the remission of individual acne lesions in vitro. Br J Dermatol 2002, 147:869-878.
38. Guy R., Kealey T. The effects of inflammatory cytokines on the isolated human sebaceous infundibulum. J Invest Dermatol 1998, 110:410-415.
39. Grunfeld C., Verdier J.A., Neese R., Moser A.H., Feingold K.R. Mechanisms by which tumor necrosis factor stimulates hepatic fatty acid synthesis in vivo. J Lipid Res 1988, 29:1327-1335.
40. Endo M., Masaki T., Seike M., Yoshimatsu H. TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c). Exp Biol Med (Maywood) 2007, 232:614-621.
41. Ruan H., Lodish H.F. Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth Factor Rev 2003, 14:447-455.
42. Sewter C., Berger D., Considine R.V., Medina G., Rochford J., Ciaraldi T., et al. Human obesity and type 2 diabetes are associated with alterations in SREBP1 isoform expression that are reproduced ex vivo by tumor necrosis factor-alpha. Diabetes 2002, 51:1035-1041.
43. Sladden M.J., Clarke P.J., Mitchell B. Infliximab-induced acne: report of a third case. Br J Dermatol 2008, 158:172.
44. Bassi E., Poli F., Charachon A., Claudepierre P., Revuz J. Infliximab-induced acne: report of two cases. Br J Dermatol 2007, 156:402-403.
45. Steels E., Peretz A., Vereecken P. Infliximab-induced acne: a new case and review of published reports. J Dermatolog Treat 2009, 20:59-60.